Brief: Xeris Biopharma Announces Research Evaluation Collaboration Agreement With Regeneron
March 30 (Reuters) - Xeris Biopharma Holdings Inc
XERS.O :
* XERIS BIOPHARMA ANNOUNCES RESEARCH EVALUATION
COLLABORATION AND
OPTION AGREEMENT WITH REGENERON FOR XERIJECT™
* XERIS BIOPHARMA HOLDINGS INC - XERIS WILL RECEIVE AN
UPFRONT
PAYMENT AND POTENTIAL MILESTONE PAYMENTS FOR PRECLINICAL
ACHIEVEMENTS
* XERIS PHARMACEUTICALS INC - SPECIFIC FINANCIAL TERMS OF
AGREEMENT WERE NOT DISCLOSED
Source text for Eikon: ID:nBw39zxNfa
Further company coverage: XERS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest